PDS Biotechnology (PDSB) 10-K2021 FY Annual report

Filed: 31 Mar 22, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abel, abstract, acute, adult, ago, air, alliance, AML, ASCO, Ashish, BioNTech, blockage, broker, caution, Chintakuntlawar, CIVIC, complementary, computationally, conserved, constitute, CPI, ctDNA, curative, Darmstadt, David, declaratory, died, embedded, enrichment, environmental, expel, fell, Finn, Flugen, Georgia, GlaxoSmithKline, HAI, hemagglutinin, hundred, IMMUNOCERV, India, Infectimune, inline, insight, instructed, intolerance, IP, ITT, Jansen, JRS, Katharine, Kathryn, KBI, leukemia, Lisa, Matthew, Mayo, Medicago, Moderna, molecularly, MRI, Multidisciplinary, Mycobacterium, myeloid, NaN, neoadjuvant, nondilutive, Olivera, oropharynx, Osivax, outlook, pathologic, PHE, plaintiff, portrayal, proceed, prudence, punitive, radiographic, ratify, reactive, recission, RECIST, redacted, refractor, renowned, Reproductive, rifampicin, robotic, Rohan, Rosener, Routman, runway, Russian, scalable, season, seasonal, seventeen, seventy, shrinkage, sick, Simon, sixteen, strike, strive, Symposium, tabulation, Ted, threat, timeline, titer, topline, transoral, UGA, unjust, unnecessary, unreimbursed, upheld, Vaxart, verification, vigorously, void, waste, weigh, wither, writing

Removed: allocated, announcement, assumed, ASU, base, bearing, Bloomquist, borrowing, carried, ceased, chairman, closest, Codification, commensurate, computing, consummation, converted, convertible, depreciable, effected, Evonik, expensing, external, finalized, fixed, formal, heading, impairment, indefinite, injunction, interested, invested, investing, leasehold, NEWTON, partner, perspective, practical, promissory, reliability, remediation, repayment, repealing, reserve, Richard, Sir, split, successor, taxed, temporarily, terminology, traded, transferred, unpaid, warrant

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PDSB transcripts

PDSB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

PDS Biotechnology Corporation:

We consent to the incorporation by reference in the registration statement (No. 333-240011) on Form S-3 and in the registration statements (No. 333-261072, No. 333-234693, No. 333-231945, No. 333-231943, No. 333-229817, No. 333-223390, 333-2223389, No. 333-216431, No. 333-216430, No 333-210042, No.333-210041, and No. 333-207545) on Form S-8 of our report dated March 31, 2022, with respect to the consolidated financial statements of PDS Biotechnology Corporation.

/s/ KPMG LLP

Short Hills, New Jersey

March 31, 2022